GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Total Assets

SLS BIO Co (XKRX:246250) Total Assets : ₩17,567 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co Total Assets?

SLS BIO Co's Total Assets for the quarter that ended in Mar. 2024 was ₩17,567 Mil.

During the past 12 months, SLS BIO Co's average Total Assets Growth Rate was -7.80% per year. During the past 3 years, the average Total Assets Growth Rate was -5.50% per year. During the past 5 years, the average Total Assets Growth Rate was 3.20% per year.

During the past 9 years, SLS BIO Co's highest 3-Year average Total Assets Growth Rate was 16.10%. The lowest was -11.90%. And the median was -0.75%.

Total Assets is connected with ROA %. SLS BIO Co's annualized ROA % for the quarter that ended in Mar. 2024 was 3.02%. Total Assets is also linked to Revenue through Asset Turnover. SLS BIO Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.12.

SLS BIO Co Total Assets Historical Data

The historical data trend for SLS BIO Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co Total Assets Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only 11,082.89 10,134.52 10,505.93 11,752.85 17,837.58

SLS BIO Co Quarterly Data
Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial - 11,831.29 12,091.99 17,837.58 17,567.10

SLS BIO Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

SLS BIO Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=13466.227+4371.357
=17,838

SLS BIO Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=13225.723+4341.376
=17,567

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SLS BIO Co  (XKRX:246250) Total Assets Explanation

Total Assets is connected with ROA %.

SLS BIO Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=534.568/( (17837.584+17567.099)/ 2 )
=534.568/17702.3415
=3.02 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

SLS BIO Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=2048.418/( (17837.584+17567.099)/ 2 )
=2048.418/17702.3415
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

SLS BIO Co Total Assets Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

SLS BIO Co (XKRX:246250) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Total Assets
Comparable Companies
XKRX:303360 XKRX:149300 XKRX:109820 XKRX:086460 XKRX:236340 XKRX:229000 XKRX:347740 XKRX:031860 XKRX:221800 XKRX:245620 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
Website
http://www.slabs.co.kr
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines